Astma klinikiniai tyrimai Koloradas
18 tyrimai dėl Astma ieško dalyvių vietose Koloradas.
Miestai Koloradas
Oficialus tyrimo tekstas (anglų kalba)
A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma
- GSK Investigational Site, Colorado Springs
Renkami dalyviai3 fazė
Amžius nuo 12 iki 17 · Visoms lytims · Atnaujinta 2026-09-30 · NCT05757102ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults
- Enveda Investigative Site, Colorado Springs
Renkami dalyviai2 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-09-24 · NCT07301255Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment
- Research Site, Aurora
Renkami dalyviai3 fazė
Amžius 6 ir vyresni · Visoms lytims · Atnaujinta 2026-09-22 · NCT07444567A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma
- Asthma & Allergy Associates - Colorado Springs, Colorado Springs
Renkami dalyviai2 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-09-22 · NCT07219173A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
- Colorado ENT & Allergy, Colorado Springs
Renkami dalyviai2 fazė
Amžius nuo 18 iki 70 · Visoms lytims · Atnaujinta 2026-09-22 · NCT06977581A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)
- Research Site 15, Colorado Springs
Renkami dalyviai3 fazė
Amžius nuo 12 iki 80 · Visoms lytims · Atnaujinta 2026-09-21 · NCT07276724PULmonary Stimulation for Asthma Relief
- National Jewish Health, Denver
Renkami dalyviai
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-09-16 · NCT07709754A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
- Teva Investigational Site 12142, Lakewood
Renkami dalyviai3 fazė
Amžius 12 ir vyresni · Visoms lytims · Atnaujinta 2026-08-31 · NCT06664619A Study of Depemokimab in Participants of 6 to 11 Years of Age
- GSK Investigational Site, Colorado Springs
Renkami dalyviai3 fazė
Amžius nuo 6 iki 11 · Visoms lytims · Atnaujinta 2026-08-26 · NCT07671001Registry of Asthma Characterization and Recruitment 3 (RACR3)
- Children's Hospital Colorado: Allergy Program, Aurora
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
Visi amžiai · Visoms lytims · Atnaujinta 2026-08-21 · NCT05272241A Study of Efficacy and Safety of Depemokimab Compared With Placebo in Adults and Adolescents With at Risk Type 2 Asthma
- GSK Investigational Site, Aurora
Renkami dalyviai3 fazė
Amžius 12 ir vyresni · Visoms lytims · Atnaujinta 2026-08-17 · NCT07456033Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
- Research Site, Denver
Renkami dalyviai3 fazė
Amžius nuo 12 iki 17 · Visoms lytims · Atnaujinta 2026-08-13 · NCT06307665Protocol CAUSE-03 / CHEETAH
- Children's Hospital Colorado: Allergy Program, Aurora
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
Amžius nuo 6 iki 17 · Visoms lytims · Atnaujinta 2026-07-01 · NCT06136091Individualizing Treatment for Asthma in Primary Care (Full Study)
- DARTNet Institute, Aurora
- University Colorado-Denver, Aurora
Renkami dalyviai4 fazė
Amžius nuo 13 iki 75 · Visoms lytims · Atnaujinta 2025-10-29 · NCT07052942Anti Inflammatory Lipid Mediators in Asthma Lipid Anti-Inflammtory Mediators in Asthma
- University of Colorado Anschutz Medical Campus, Aurora
Renkami dalyviai2 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2025-06-10 · NCT03762395Study to Improve Deployment Related Asthma by Using L-Citrulline Supplementation
- National Jewish Health, Denver
Renkami dalyviai2 fazė
Amžius nuo 18 iki 70 · Visoms lytims · Atnaujinta 2023-04-06 · NCT05259904Obesity, Metabolic Dysregulation and the Airway Epithelium in Asthmatics
- University of Colorado, Aurora
Renkami dalyviai
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2023-02-02 · NCT03215836Reslizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) Study
- National Jewish Health, Denver
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2017-09-14 · NCT02947945Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.